Kagehiro Amano

Moderation of hemophilia A phenotype by the factor V R506Q mutation

WC Nichols, Kagehiro Amano, PM Cacheris et al. · Blood · 1996 · 144 citations · Full text

Medicine, Genetics, Hematology +14

Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand Factor

Suzuki Suzuki, Morio Arai, Kagehiro Amano et al. · Thrombosis and Haemostasis · 1996 · 94 citations

Medicine, Molecular Biology, Pathology +14

A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A

Midori Shima, Kagehiro Amano, Yoshiyuki Ogawa et al. · Journal of Thrombosis and Haemostasis · 2023 · 75 citations · Full text

Medicine, Hematology, Pharmacology +13

Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden

Keiji Nogami, Keiko Shinozawa, Kenichi Ogiwara et al. · Blood · 2014 · 71 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +15

The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII

Kagehiro Amano, Rita Sarkar, Susan Pemberton et al. · Blood · 1998 · 47 citations · Full text

Medicine, Genetics, Hematology +16